Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime?

Roberto H. Barbier; Cindy H. Chau; William D. Figg

doi:10.1111/bju.14869

Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime?

Roberto H. Barbier, Cindy H. Chau, William D. Figg^*

^*Corresponding author for this work

Surgery

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	549-550
Number of pages	2
Journal	BJU International
Volume	124
Issue number	4
DOIs	https://doi.org/10.1111/bju.14869
State	Published - 1 Oct 2019

Access to Document

10.1111/bju.14869

Cite this

@article{c191cec2b2654ae6978ad838b61c045d,

title = "Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime?",

author = "Barbier, {Roberto H.} and Chau, {Cindy H.} and Figg, {William D.}",

note = "Funding Information: This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.",

year = "2019",

month = oct,

day = "1",

doi = "10.1111/bju.14869",

language = "English",

volume = "124",

pages = "549--550",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley and Sons Inc",

number = "4",

}

TY - JOUR

T1 - Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance

T2 - partners in crime?

AU - Barbier, Roberto H.

AU - Chau, Cindy H.

AU - Figg, William D.

N1 - Funding Information: This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85073217693&partnerID=8YFLogxK

U2 - 10.1111/bju.14869

DO - 10.1111/bju.14869

M3 - Editorial

C2 - 31908596

AN - SCOPUS:85073217693

SN - 1464-4096

VL - 124

SP - 549

EP - 550

JO - BJU International

JF - BJU International

IS - 4

ER -

Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime?

Access to Document

Fingerprint

Cite this